Clinical Trial Update: Evaluation of Anti-mullerian Hormone(AMH) Levels as a Predictive Factor of Response to Weight Loss Treatment in Obese Infertile Women With Poly Cystic Ovary(PCOS) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether anti-Müllerian hormone (AMH) levels can predict response to a weight-loss treatment in obese infertile women with polycystic ova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Obesity
• Polycystic Ovary Syndrome

Snippet

Sponsor: Royan Institute | Conditions: Infertility | Phase 3 | Status: COMPLETED